Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 13/20 | 0.67 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CCR3 | P51677 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3148969 | 0.83 | MCHR1 (0.58) | SIGMAR1MCHR1CCR3 | |
| SCHEMBL4034602 | 0.82 | SIGMAR1 (0.83) | SIGMAR1MCHR1MEN1KMT2A | |
| SCHEMBL4034921 | 0.82 | MCHR1 (0.77) | SIGMAR1MCHR1MEN1KMT2A | |
| SCHEMBL6389014 | 0.81 | SIGMAR1 (0.81) | SIGMAR1MCHR1 | |
| SCHEMBL4234608 | 0.81 | MCHR1 (0.69) | MCHR1CCR3 | |
| SCHEMBL4242788 | 0.80 | DRD4 (0.60) | MCHR1CCR3 | |
| SCHEMBL7487718 | 0.80 | SIGMAR1 (0.74) | SIGMAR1MCHR1MEN1KMT2ACCR3 | |
| SCHEMBL4031569 | 0.79 | SIGMAR1 (0.67) | SIGMAR1MCHR1MEN1KMT2ACCR3 | |
| SCHEMBL3135668 | 0.79 | MCHR1 (0.66) | MCHR1CCR3 | |
| SCHEMBL4034737 | 0.79 | SIGMAR1 (0.81) | SIGMAR1MEN1KMT2ACCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081825-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 2010-04-01 | — | — | US | claimed |
| EP-2098509-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | Taisho Pharmaceutical Co. Ltd. (JP) | 2009-09-09 | — | — | EP | claimed |
| US-20100081825-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-2098509-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | Taisho Pharmaceutical Co. Ltd. (JP) | 2009-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081825-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | MCHR1, MCHR2, MC5R | SIGMAR1 96/4885MCHR1 1/4885MEN1 1012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.